Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 964,677 |
|
|||||
| News | - | ||||||
| Day High | 3.33 | Low High |
|||||
| Day Low | 3.08 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Cellectar Biosciences Inc | CLRB | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.23 | 7.44% | 3.32 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 3.10 | 3.08 | 3.33 | 3.16 | 3.09 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,289 | 964,677 | US$ 3.23 | US$ 3,119,825 | - | 1.33 - 4.45 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:12:14 | formt | 100 | US$ 3.32 | USD |
Cellectar Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 0 | 30.45M | - | 0 | -37.98M | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cellectar Biosciences News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CLRB Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.09 | 3.33 | 2.942 | 3.06 | 730,589 | 0.23 | 7.44% |
| 1 Month | 4.00 | 4.1499 | 2.942 | 3.34 | 831,979 | -0.68 | -17.00% |
| 3 Months | 3.56 | 4.45 | 2.942 | 3.65 | 995,363 | -0.24 | -6.74% |
| 6 Months | 2.42 | 4.45 | 1.87 | 3.42 | 1,162,293 | 0.90 | 37.19% |
| 1 Year | 1.55 | 4.45 | 1.33 | 3.19 | 757,200 | 1.77 | 114.19% |
| 3 Years | 1.60 | 6.7568 | 0.337 | 2.29 | 433,476 | 1.72 | 107.50% |
| 5 Years | 2.33 | 6.7568 | 0.337 | 2.08 | 561,876 | 0.99 | 42.49% |
Cellectar Biosciences Description
| Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and better safety as a result of fewer off-target effects. Its lead PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells. |
